Status:

UNKNOWN

Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.

Lead Sponsor:

Clinica Universidad de Navarra, Universidad de Navarra

Conditions:

Hepatic Carcinoma

Hepatic Metastasis

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

The goal of this double-blind clinical trial is to compare the efficacy of octreotide versus placebo in laparoscopic hepatectomy surgery in patients diagnosed with resectable hepatocarcinoma or liver ...

Detailed Description

The drug will be administered during surgery, after anesthetic induction, and will be withdrawn at the end of surgery before leaving the operating room. The patient will not receive any visit or requ...

Eligibility Criteria

Inclusion

  • Patients diagnosed with hepatic lesions who are going to undergo hepatectomy via laparoscopy.
  • The patient must be between 18 and 80 years old.
  • The patient, or his/her representative, has given his/her consent to participate in the study.
  • The patient must, in the opinion of the investigator, be able to comply with all the requirements of the clinical trial.
  • The patient must not be allergic to the drug.

Exclusion

  • History of hypersensitivity to the drug to be administered.
  • Children under 18 years of age.
  • Urgent intervention.
  • Intervention performed in an open manner (not laparoscopic).
  • Patient's refusal to participate in the study.
  • Contraindication to receive octreotide.
  • Women of childbearing age (those women who are in the period between menarche and menopause). Having to present a negative pregnancy test to take part in the study.
  • Pregnant or lactating women, given the absence of studies of this drug in this patient profile.

Key Trial Info

Start Date :

August 14 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 30 2025

Estimated Enrollment :

62 Patients enrolled

Trial Details

Trial ID

NCT06085976

Start Date

August 14 2023

End Date

November 30 2025

Last Update

October 17 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinica Universidad de Navarra

Pamplona, Spain, 31007